Avisa Approves 5 New Pens for Diabetes and Obesity Treatment

Globo

Jovem Pan News

View article

EBC

View article

+2 Reposted by 2 other sources

Lean Right

Factuality

Ownership

The National Agency for Health Surveillance (Anvisa) approved the registration of five new injectable medicines for the treatment of type 2 diabetes and obesity. The products will be marketed in the form of application pens containing semaglutide or liraglutide – substances that act directly on the patient's metabolism, helping to control blood glucose and weight loss.

BNews

Factuality

Ownership

With the new records, Anvisa already counts 20 approvals of GLP-1 slimming pens this year

Polêmica Paraíba

Factuality

Ownership

Photo: Reproduction/Caroline Morais (Ministry of Health)The National Agency for Health Surveillance (Anvisa) approved, on Thursday (29), the registration of five new injectable pens used in the treatment of diabetes and obesity. The drugs are produced with substances such as liraglutide and Semaglutide. Three of the products are indicated for the treatment of diabetes: Aribet, Embeltah and Sevema. The other two, Lyrza and Wylovol, [...] The post…

Radio Guaíba

Factuality

Ownership

The National Agency for Health Surveillance (Anvisa) approved, on last Thursday (29), the registration of five new injectable medicines for the treatment of type 2 diabetes and obesity. The products will be marketed in the form of applicators pens containing semaglutide or liraglutide – substances that act directly in the metabolism of the patient, helping in the control of blood glucose... Read more » The post Anvisa approves 5 new pens for the…

Forbes Brasil

Factuality

Ownership

Forbes, the world's most renowned business and economic magazine. Drugs are produced by two Indian laboratories The post Anvisa Approves 5 New Pens for Diabetes and Obesity Treatment apareceu primeiro em Forbes Brasil.